CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
This is a single-center, randomized, blinded, controlled trial assessing the effects on the skin microbiome in patients with eczema of amend...
Houston, Texas, United States of America
The purpose of this study is to evaluate the safety and tolerability of XmAb27564 following multiple doses among participants with plaque psoriasis a...
Phase 1
Webster, Texas, United States and 8 other locations
This trial is designed to evaluate multiple compounds in participants with moderate to severe atopic dermatitis (AD).
Phase 2
Houston, Texas, United States and 16 other locations
The objective of this study is to assess the efficacy and safety of upadacitinib for the treatment of adolescent and adult participants with moderate...
Phase 3
Webster, Texas, United States and 180 other locations
The purpose of this study is to measure how well taking lebrikizumab alone works for participants with fewer places on the body with eczema ...
Phase 4
Houston, Texas, United States and 74 other locations
The primary objective of the study is to assess the long-term safety of dupilumab in pediatric participants with AD.The secondary objectives of the s...
Phase 3
Bellaire, Texas, United States and 83 other locations
The purpose of this study is to assess the efficacy and safety of barzolvolimab in adults with Atopic Dermatitis
Phase 2
Sugar Land, Texas, United States and 24 other locations
The main purpose of this study is to assess the long-term safety and efficacy of lebrikizumab in participants 6 Months to \<18 years of age with mode...
Phase 3
Bellaire, Texas, United States and 95 other locations
The purpose of this study is to learn about the safety and effects of 2 study medicines (PF-07275315 and PF-07264660) for the treatment of atopic der...
Phase 2
Houston, Texas, United States and 98 other locations
This study is being conducted to establish the efficacy of ruxolitinib cream in participants with moderate AD who had an inadequate response to, or a...
Phase 3
Houston, Texas, United States and 96 other locations
Clinical trials
Research sites
Resources
Legal